Jakafi XR is Approved by the FDA for Myelofibrosis
The announcement on May 1st, 2026, that Jakafi XR has been approved by the FDA for patients managing myelofibrosis offers a new dosing option . Prior to this announcement, Jakafi was widely used in treatment






